More Than Ever, New Therapies Require Reimbursement Support

(sponsored by RxCrossroads by McKesson) Reimbursement in the specialty therapy arena is complex. In this current environment of heightened competition, rising prices and the growth of highly specialized, complex therapies, biopharma companies need assistance maneuvering the ever-changing landscape of reimbursement […]

Read More